Evidence map›Paper›PMID 36233262›Full record

ReviewInternational journal of molecular sciences2022

Regulation of Mesothelial Cell Fate during Development and Human Diseases.

Toshiaki Taniguchi, Hiroyuki Tomita, Tomohiro Kanayama, Kazumasa Mogi, Yoshihiro Koya, Yoshihiko Yamakita, Masato Yoshihara, Hiroaki Kajiyama, Akira Hara

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Toshiaki TaniguchiDepartment of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
Hiroyuki TomitaDepartment of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.ORCID 0000-0002-3291-0274
Tomohiro KanayamaDepartment of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
Kazumasa MogiDepartment of Obstetrics and Gynecology, Graduate School of Medicine, Nagoya University, Nagoya 466-8560, Japan.
Yoshihiro KoyaBell Research Center, Department of Obstetrics and Gynecology Collaborative Research, Graduate School of Medicine, Nagoya University, Nagoya 466-8560, Japan.
Yoshihiko YamakitaBell Research Center, Department of Obstetrics and Gynecology Collaborative Research, Graduate School of Medicine, Nagoya University, Nagoya 466-8560, Japan.
Masato YoshiharaDepartment of Obstetrics and Gynecology, Graduate School of Medicine, Nagoya University, Nagoya 466-8560, Japan.ORCID 0000-0001-5811-3137
Hiroaki KajiyamaDepartment of Obstetrics and Gynecology, Graduate School of Medicine, Nagoya University, Nagoya 466-8560, Japan.ORCID 0000-0003-0493-1825
Akira HaraDepartment of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.ORCID 0000-0002-5554-8060
Nagoya University · JPGifu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesothelial cells (MCs) play a classic role in maintaining homeostasis in pleural, peritoneal, and pericardial cavities. MCs work as lubricants to reduce friction between organs, as regulators of fluid transport, and as regulators of defense mechanisms in inflammation. MCs can differentiate into various cells, exhibiting epithelial and mesenchymal characteristics. MCs have a high potential for differentiation during the embryonic period when tissue development is active, and this potential decreases through adulthood. The expression of the Wilms' tumor suppressor gene (

Indexed as

LubricantsPleuraAdultAnimalsCell DifferentiationHumansMiceLubricantscancer-associated fibroblastdifferentiationlineage tracingmesothelial cellWt1

Identifiers

PMID36233262
PMCPMC9569588
OpenAlexW4303709885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.